A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.

UNLABELLED: Cyclooxygenase-2 (COX-2) is associated with tumour promotion, inhibition of apoptosis, angiogenesis and metastasis. Celecoxib, a selective COX-2 inhibitor was investigated, in patients with clinically localized prostate cancer using immunohistochemistry. PATIENTS AND METHODS: Patients w...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Sooriakumaran, P, Coley, H, Fox, S, Macanas-Pirard, P, Lovell, D, Henderson, A, Eden, C, Miller, P, Langley, SE, Laing, R
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: 2009